Security key
881624209
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 1,148,777,709
- Total 13F shares
- 712,590,449
- Share change
- +871,453
- Total reported value
- $11,941,932,547
- Put/Call ratio
- 53%
- Price per share
- $16.76
- Number of holders
- 533
- Value change
- +$36,824,124
- Number of buys
- 250
- Number of sells
- 230
Report period
Q2 2025
Institutions
533
Top holders
10
TEVA full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 881624209
Recent filing periods:
Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
7.2%
|
82,742,016
|
$1,271,744,786 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.5%
|
52,223,893
|
$802,681,237 | — | 31 Mar 2025 | |
| Ion Asset Management Ltd. |
13F
|
Company |
3.4%
|
39,033,500
|
$599,944,895 | — | 31 Mar 2025 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
3.3%
|
37,794,068
|
$578,331,000 | — | 31 Mar 2025 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
2.5%
|
29,189,316
|
$448,639,787 | — | 31 Mar 2025 | |
| Lingotto Investment Management LLP |
13F
|
Company |
2.4%
|
27,853,943
|
$428,115,104 | — | 31 Mar 2025 | |
| Phoenix Financial Ltd. |
13F
|
Company |
2.4%
|
27,464,572
|
$422,129,965 | — | 31 Mar 2025 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
2.3%
|
26,335,422
|
$404,775,000 | — | 31 Mar 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
2.2%
|
25,550,000
|
$392,703,500 | — | 31 Mar 2025 | |
| Harel Insurance Investments & Financial Services Ltd. |
13F
|
Company |
1.9%
|
22,055,547
|
$338,989,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
17,321,325
|
$266,228,765 | — | 31 Mar 2025 | |
| PointState Capital LP |
13F
|
Company |
1.3%
|
15,131,488
|
$232,570,971 | — | 31 Mar 2025 | |
| Duquesne Family Office LLC |
13F
|
Company |
1.3%
|
14,879,750
|
$228,702,000 | — | 31 Mar 2025 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
14,778,641
|
$227,147,712 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.96%
|
10,997,926
|
$169,038,130 | — | 31 Mar 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.88%
|
10,125,478
|
$155,628,597 | — | 31 Mar 2025 | |
| Slate Path Capital LP |
13F
|
Company |
0.84%
|
9,655,998
|
$148,412,689 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.8%
|
9,194,608
|
$140,570,256 | — | 31 Mar 2025 | |
| AustralianSuper Pty Ltd |
13F
|
Company |
0.75%
|
8,562,222
|
$131,601,352 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.66%
|
7,531,223
|
$115,754,897 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.61%
|
7,053,671
|
$108,414,916 | — | 31 Mar 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.55%
|
6,283,688
|
$96,077,590 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.52%
|
5,983,928
|
$91,972,973 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.53%
|
6,078,241
|
$91,660,232 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.48%
|
5,495,489
|
$84,465,666 | — | 31 Mar 2025 | |
| SOUND SHORE MANAGEMENT INC /CT/ |
13F
|
Company |
0.47%
|
5,452,089
|
$83,798,608 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.46%
|
5,301,245
|
$81,480,136 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
5,218,367
|
$80,206,301 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
4,687,252
|
$72,043,058 | — | 31 Mar 2025 | |
| Parsifal Capital Management, LP |
13F
|
Company |
0.37%
|
4,202,187
|
$64,587,614 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.35%
|
4,069,266
|
$62,544,618 | — | 31 Mar 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
0.35%
|
4,020,628
|
$61,797,052 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.35%
|
3,965,257
|
$60,946,006 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.32%
|
3,629,662
|
$55,787,905 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.31%
|
3,537,324
|
$54,368,670 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.3%
|
3,410,142
|
$52,413,883 | — | 31 Mar 2025 | |
| FIL Ltd |
13F
|
Company |
0.3%
|
3,407,863
|
$52,378,854 | — | 31 Mar 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.28%
|
3,225,613
|
$49,577,672 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.27%
|
3,130,400
|
$48,114,248 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.26%
|
2,990,340
|
$45,961,525 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.26%
|
2,933,131
|
$45,082,223 | — | 31 Mar 2025 | |
| TODD ASSET MANAGEMENT LLC |
13F
|
Company |
0.26%
|
2,932,742
|
$45,076,242 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.25%
|
2,853,091
|
$43,852,008 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.24%
|
2,770,120
|
$42,577,000 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.24%
|
2,748,868
|
$42,244,225 | — | 31 Mar 2025 | |
| Capital International Investors |
13F
|
Company |
0.24%
|
2,701,061
|
$41,515,304 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.23%
|
2,656,277
|
$40,826,978 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.23%
|
2,589,607
|
$39,802,259 | — | 31 Mar 2025 | |
| NORGES BANK |
13F
|
Company |
0.23%
|
2,585,200
|
$39,734,524 | — | 31 Mar 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.22%
|
2,504,007
|
$38,486,588 | — | 31 Mar 2025 |
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2025
As of 30 Jun 2025,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
533 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
712,590,449 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD., Ion Asset Management Ltd., Phoenix Financial Ltd., Harel Insurance Investments & Financial Services Ltd., Clal Insurance Enterprises Holdings Ltd, Migdal Insurance & Financial Holdings Ltd., Lingotto Investment Management LLP, and Rubric Capital Management LP.
This page lists
536
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
553
Q2 2025 holders
533
Holder diff
-20
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.